Rheumatoid Arthritis Recruiting Phase 2 Trials for Anifrolumab (DB11976)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

DBCOND0027961 (Rheumatoid Arthritis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03435601A Study to Target the Type I IFN Receptor by Administrating Anifrolumab in RA Patients With a High IFN Signature (TarIFNiRA)Treatment